Your search returned 26 studies. (Get alerts for new studies):
- Post Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic - Lymphomas - Multiple Myeloma - Myelodysplastic Syndrome - Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - AML
1 Location available
- Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
Conditions: Blood and Marrow Transplant (BMT) - Lymphomas: Non-Hodgkin - Peripheral T-Cell
2 Locations available
- Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Tr
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma
1 Location available
- T-cell Depleted Alternative Donor Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Lymphomas - Bone Marrow Failure - Hemoglobinopathy - Immune Deficiency - Osteopetrosis
1 Location available
- SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma - Lymphoma, Primary Cutaneous Anaplastic Large Cell - Lymphomatoid Papulosis - Mycosis Fungoides - Skin Lymphoma - Cutaneous Lymphomas - Lymphoma - Hematologic Disorder
1 Location available
- Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204)
Conditions: Leukemia - Leukemia Chronic Myelogenous Leukemia (CML) - Blood and Marrow Transplant (BMT) - Myelodysplastic Syndromes (MDS) - Lymphomas: Non-Hodgkin
1 Location available
- A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Conditions: Neoplasms - Lymphoma
1 Location available
- TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell Lymphomas
Conditions: Lymphoma, Non-Hodgkin - Cutaneous Lymphoma - Large B Cell Diffuse Lymphoma - Mantle Cell Lymphoma - Marginal Zone B-Cell Lymphoma - Peripheral T-cell Lymphoma, Large Cell - Waldenstrom Macroglobulinemia
1 Location available
- Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Conditions: Relapsed Lymphomas - Refractory Lymphomas
1 Location available
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Conditions: MDS - Leukemias - Lymphomas
2 Locations available
- Safety and PK Study of RRx-001 in Cancer Subjects
Conditions: Malignant Solid Tumor - Lymphomas
2 Locations available
- Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Cancer - Solid Tumors - Lymphoma - Malignancy
3 Locations available
- Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
Conditions: Lymphoma - Non-Hodgkin's Lymphoma
1 Location available
- Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
Conditions: Neoplasms - Lymphomas
13 Locations available
- Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas
Conditions: Non-Hodgkin Lymphomas
2 Locations available
- An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Neoplasms - Lymphoma
1 Location available
- LMP400 and LMP776 in Treating Patients With Relapsed Solid Tumors or Lymphomas
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Imexon for Relapsed Follicular and Aggressive Lymphomas
Conditions: Follicular Lymphoma - Diffuse Large B Cell Lymphoma - Mantle Cell Lymphoma - Burkitt's Lymphoma
1 Location available
- Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Conditions: Solid Tumors - Lymphomas
1 Location available
- A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
Conditions: T-cell Lymphomas - T-cell Leukemia - Sezary Syndrome - Mycosis Fungoides
1 Location available
- A Phase II Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
Conditions: Lymphoma, Non-Hodgkin - Lymphoma - Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell - Lymphomas: Non-Hodgkin
1 Location available
- Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
Conditions: Lymphoma - B-cell Lymphoma - Non Hodgkin Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumors - Lymphomas
2 Locations available
- A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumor - Lymphomas
3 Locations available
- A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
Conditions: Advanced Solid Tumor - Lymphoma
1 Location available
|